Detection of autoantibodies in children with Crohn’s disease depending on the clinical features of the disease
https://doi.org/10.53529/2500-1175-2025-3-115-119
About the Authors
A. A. Zhuzhula
Federal State Autonomous Institution “National Medical Research Center for Children’s Health” of the Ministry of Health of the Russian Fedeeration
Russian Federation
Russian Federation
Anastasia A. Zhuzhula
119991; Lomonosovsky prospect, 2, building 1; Moscow
O. V. Kurbatova
Federal State Autonomous Institution “National Medical Research Center for Children’s Health” of the Ministry of Health of the Russian Fedeeration
Russian Federation
Russian Federation
Olga V. Kurbatova
119991; Lomonosovsky prospect, 2, building 1; Moscow
S. V. Petrichuk
Federal State Autonomous Institution “National Medical Research Center for Children’s Health” of the Ministry of Health of the Russian Fedeeration
Russian Federation
Russian Federation
Svetlana V. Petrichuk
119991; Lomonosovsky prospect, 2, building 1; Moscow
M. A. Snovskaya
Federal State Autonomous Institution “National Medical Research Center for Children’s Health” of the Ministry of Health of the Russian Fedeeration
Russian Federation
Russian Federation
Marina A. Snovskaya
119991; Lomonosovsky prospect, 2, building 1; Moscow
K. A. Mokretsova
Federal State Autonomous Institution “National Medical Research Center for Children’s Health” of the Ministry of Health of the Russian Fedeeration
Russian Federation
Russian Federation
Kadria A. Mokretsova
119991; Lomonosovsky prospect, 2, building 1; Moscow
A. O. Anushenko
Federal State Autonomous Institution “National Medical Research Center for Children’s Health” of the Ministry of Health of the Russian Fedeeration
Russian Federation
Russian Federation
Anton O. Anushenko
119991; Lomonosovsky prospect, 2, building 1; Moscow
E. L. Semikina
Federal State Autonomous Institution “National Medical Research Center for Children’s Health” of the Ministry of Health of the Russian Fedeeration; The State Education Institution of Higher Professional Training The First Sechenov Moscow State Medical University under Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Elena L. Semikina
119991; Lomonosovsky prospect, 2, building 1; st. Trubetskaya, d. 8, building 2; Moscow
A. S. Potapov
Federal State Autonomous Institution “National Medical Research Center for Children’s Health” of the Ministry of Health of the Russian Fedeeration; The State Education Institution of Higher Professional Training The First Sechenov Moscow State Medical University under Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Alexander S. Potapov
119991; Lomonosovsky prospect, 2, building 1; st. Trubetskaya, d. 8, building 2; Moscow
A. P. Fisenko
Federal State Autonomous Institution “National Medical Research Center for Children’s Health” of the Ministry of Health of the Russian Fedeeration
Russian Federation
Russian Federation
Andrey P. Fisenko
119991; Lomonosovsky prospect, 2, building 1; Moscow
References
1. Svirava A.M., Shiryaeva A.V. Crohn’s disease. Modern methods of diagnosis and treatment. Stolypin Bulletin. 2022; 4 (5): 2721–2739. (In Russ.)
2. Clinical recommendations “Crohn’s Disease” / Approved by the professional association “Union of Pediatricians of Russia”, approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation — 2020. (In Russ.) https://cr.minzdrav.gov.ru/recomend/682_1.
3. Gurina O.P., Stepanova A.A., Dementieva E.A., et al. (2018). Features of autoimmune reactions in children with Crohn’s disease. Clinical Laboratory Diagnostics. 2018; 63 (1): 44–50. (In Russ.) doi: 10.18821.0869-2084-2018-63-1-44-50.
4. Kuznetsova D.A., Lapin S.V., Shchukina O.B. (2020). Diagnostic and prognostic significance of serological markers of inflammatory bowel diseases (literature review). Almanac of Clinical Medicine. 2020; 48 (6): 364–374. (In Russ.) doi: 10.18786/2072-0505-2020-48-061.
5. Aleksandrova E.N., Novikov A.A., Lukina G.V., Parfenov A.I. Clinical value of antibodies in inflammatory bowel diseases.Terapevticheskii arkhiv. 2021; 93 (2): 228–235. (In Russ.) doi: 10.26442/00403660.2021.02.200610.
6. Sendid B., Cornu M., Cordier C., et al. From ASCA breakthrough in Crohn’s disease and Candida albicans research to thirty years of investigations about their meaning in human health. Autoimmun Rev. 2024 Feb; 23 (2): 103486. doi: 10.1016/j.autrev.2023.103486. Epub 2023 Nov 30. PMID: 38040100.
7. Tat’yanina O.F., Potapov A.S., Namazova L.S., Tsimbalova E.G., Kucherenko A., Lokhmatov M. Faecalcalprotectin in noninvasive diagnostics of the inflammatory enteric diseases among children. Pediatric pharmacology. 2008; 5 (3): 46–51. (In Russ.)
8. Tsvetkova V.S., Semikina E.L., Potapov A.S. Biomarkers of inflammatory activity in Crohn’s disease and ulcerative colitis in children. Russian Pediatric Journal. 2021; 24 (S): 64.
9. Zhuzhula A.A., Kurbatova O.V., Petrichuk S.V., et al. Diagnostic significance of the determination of antinuclear antibodies in children with autoimmune hepatitis. Allergology and Immunology in Pediatrics. 2024; (1): 36–40. (In Russ.) doi: 10.53529/2500-1175-2024-1-36-40.
Review
For citations:
Zhuzhula A.A., Kurbatova O.V., Petrichuk S.V., Snovskaya M.A., Mokretsova K.A., Anushenko A.O., Semikina E.L., Potapov A.S., Fisenko A.P. Detection of autoantibodies in children with Crohn’s disease depending on the clinical features of the disease. Allergology and Immunology in Paediatrics. 2025;(3):115-119. (In Russ.) https://doi.org/10.53529/2500-1175-2025-3-115-119
Views:
32
Email this article 